{
"all_guidance": [
	{
		"EntryID" : 32,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Alpha-adrenergic Agonists",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive, central acting",
		"Exclusion" : null,
		"Rationale" : "High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 90,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Proton Pump Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Scheduled use for >8 weeks unless for high-risk patients (eg, oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett esophagitis, pathological hypersecretory condition, or demonstrated need for maintenance treatment (eg, because of failure of drug discontinuation trial or H2-receptor antagonists)",
		"Exclusion" : null,
		"Rationale" : "Risk of Clostridium difficile infection and bone loss and fractures",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 118,
		"DiseaseState" : "Heart Failure with Reduced Ejection Fraction (HFrEF)",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Calcium Channel Blocking Agents, Nondihydropyridines",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Reduced Ejection Fraction",
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 119,
		"DiseaseState" : "Asymptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nonsteroidal Anti-inflammatory Drugs",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 120,
		"DiseaseState" : "Asymptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nonsteroidal Anti-inflammatory Drugs",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "COX-2 inhibitors",
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 123,
		"DiseaseState" : "Symptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nonsteroidal Anti-inflammatory Drugs",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 124,
		"DiseaseState" : "Symptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nonsteroidal Anti-inflammatory Drugs",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "COX-2 inhibitors",
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 127,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Alpha-adrenergic Agonists",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Non-selective peripheral alpha-1 blockers",
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 128,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Angiotensin-converting Enzyme (ACE) Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 132,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Tricyclics",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Tertiary",
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 138,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Benzodiazepines",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 139,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Glucocorticoids",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 145,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nonbenzodiazepine Receptor Agonists",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 146,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Benzodiazepines",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 154,
		"DiseaseState" : "Dementia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Benzodiazepines",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 158,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Benzodiazepines",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 162,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Tricyclics",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 163,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Selective Serotonin Reuptake Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 164,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Serotonin and Norepinephrine Reuptake Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 184,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Serotonin and Norepinephrine Reuptake Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 185,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Selective Serotonin Reuptake Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 186,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Tricyclics",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 190,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Angiotensin II Receptor Antagonists",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "another RAS inhibitor",
		"Inclusion" : "chronic kidney disease (CKD) stage 3 or higher",
		"Exclusion" : null,
		"Rationale" : "Increased risk of hyperkalemia ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 191,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Angiotensin-converting Enzyme (ACE) Inhibitors",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "another RAS inhibitor",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of hyperkalemia ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 195,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Opioid",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "benzodiazepines",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of overdose",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 196,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Opioid",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "gabapentin",
		"Inclusion" : null,
		"Exclusion" : "when\ntransitioning from opioid therapy\nto gabapentin or pregabalin, or\nwhen using gabapentinoids to\nreduce opioid dose, although\ncaution should be used in all\ncircumstances.",
		"Rationale" : "Increased risk of severe\nsedation-related adverse\nevents, including respiratory\ndepression and death",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 197,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Opioid",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "pregabalin",
		"Inclusion" : null,
		"Exclusion" : "when transitioning from opioid therapy to gabapentin or pregabalin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",
		"Rationale" : "Increased risk of severe\nsedation-related adverse\nevents, including respiratory\ndepression and death",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 202,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Benzodiazepines",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls and\nof fracture ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 203,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Nonbenzodiazepine Receptor Agonists",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls and\nof fracture ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 204,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Nonbenzodiazepine Receptor Agonists",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls and\nof fracture ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 205,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Opioid",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 206,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Glucocorticoids",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Non-steroidal Anti-inflammatory Drugs",
		"Inclusion" : "Oral or parenteral",
		"Exclusion" : null,
		"Rationale" : "Increased risk of peptic ulcer\ndisease or gastrointestinal\nbleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Use GI protection if not possible",
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 209,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Alpha-adrenergic Blocking Agents",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "loop diuretics",
		"Inclusion" : "Older female, peripheral",
		"Exclusion" : "Conditions warrant both drugs",
		"Rationale" : "Increased risk of urinary\nincontinence in older women",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 125,
		"DiseaseState" : "Asymptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Thiazolidinediones",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 171,
		"DiseaseState" : "Chronic Kidney Disease (CKD)",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nonsteroidal Anti-inflammatory Drugs",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Creatinine clearance <30 mL\/min (CKD stage 4 or higher), non-COX and COX selective,\r\noral and parenteral, nonacetylated\r\nsalicylates",
		"Exclusion" : null,
		"Rationale" : "May increase risk of acute kidney injury and further decline of renal function",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "class",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 1,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Brompheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 2,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Carbinoxamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 3,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Chlorpheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 4,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Clemastine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 5,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Cyproheptadine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 6,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Dexbrompheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 7,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Dexchlorpheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 8,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Dimenhydrinate",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 9,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Diphenhydramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity.  Use of diphenhydramine in situations such as acute treatment of severe allergic reaction may be appropriate.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 10,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Doxylamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 11,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Hydroxyzine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 12,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Meclizine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 13,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Promethazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 14,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Pyrilamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 15,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Triprolidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic; clearance reduced with advanced age, and tolerance develops when used as hypnotic; risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 16,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Atropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 17,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Belladonna alkaloids",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 18,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Clidinium-chlordiazepoxide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 19,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Dicyclomine Homatropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 20,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Hyoscyamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 21,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Methscopolamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 22,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Propantheline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 23,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Scopolamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, uncertain effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 24,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Benztropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Not recommended for prevention or treatment of extrapyramidal symptoms with antipsychotics; more effective agents available for treatment of Parkinson disease",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 25,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Trihexyphidyl",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Not recommended for prevention or treatment of extrapyramidal symptoms with antipsychotics; more effective agents available for treatment of Parkinson disease",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 27,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Nitrofurantoin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "in individuals with creatinine clearance <30 mL\/min or for long-term suppression",
		"Exclusion" : null,
		"Rationale" : "Potential for pulmonary toxicity, hepatoxicity, and\nperipheral neuropathy, especially with long-term use;\nsafer alternatives available",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 28,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Doxazosin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of orthostatic hypotension and associated harms, especially in older adults; not recommended as routine treatment for hypertension; alternative agents have superior risk\/benefit profile",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 29,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Prazosin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of orthostatic hypotension and associated harms, especially in older adults; not recommended as routine treatment for hypertension; alternative agents have superior risk\/benefit profile",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 30,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Terazosin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of orthostatic hypotension and associated harms, especially in older adults; not recommended as routine treatment for hypertension; alternative agents have superior risk\/benefit profile",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 31,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Clonidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 33,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Guanabenz",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 34,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Guanfacine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 35,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Methyldopa",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : null,
		"Rationale" : "High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 36,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Reserpine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "use as an antihypertensive",
		"Exclusion" : "(<0.1 mg\/day), ",
		"Rationale" : "High risk of adverse CNS effects; may cause bradycardia and orthostatic hypotension; not recommended as routine treatment for hypertension",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 37,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Disopyramide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May induce heart failure in older adults because of potent negative inotropic action; strongly anticholinergic; other antiarrhythmic drugs preferred",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 38,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Dronedarone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Permanent Atrial Fibrillation and severe or recently decompensated heart failure",
		"Exclusion" : null,
		"Rationale" : "Worse outcomes have been reported in patients taking\ndronedarone who have permanent atrial fibrillation or\nsevere or recently decompensated heart failure.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 39,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Digoxin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Avoid this rate control agent as FIRSTLINE therapy for atrial fibrillation or Afib\nIf used for atrial fibrillation or heart failure, avoid dosages >0.125 mg\/day",
		"Exclusion" : null,
		"Rationale" : "Use in atrial fibrillation: should not be used as a first-line\nagent in atrial fibrillation, because there are safer and\nmore effective alternatives for rate control supported by\nhigh-quality evidence.\nUse in heart failure: evidence for benefits and harms of\ndigoxin is conflicting and of lower quality; most but not all\nof the evidence concerns use in HFrEF. There is strong\nevidence for other agents as first-line therapy to reduce\nhospitalizations and mortality in adults with HFrEF. In\nheart failure, higher dosages are not associated with\nadditional benefit and may increase risk of toxicity.\nDecreased renal clearance of digoxin may lead to\nincreased risk of toxic effects; further dose reduction may\nbe necessary in those with stage 4 or 5 chronic kidney\ndisease.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 40,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Nifedipine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "IR form",
		"Exclusion" : null,
		"Rationale" : "Potential for hypotension; risk of precipitating myocardial\nischemia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 41,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Amiodarone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "first-line therapy for atrial fibrillation",
		"Exclusion" : "patients WITH ATRIAL FIBRILLATION that have heart failure or substantial left ventricular hypertrophy",
		"Rationale" : " Effective for maintaining sinus rhythm but has greater\ntoxicities than other antiarrhythmics used in atrial\nfibrillation; may be reasonable first-line therapy in patients\nwith concomitant heart failure or substantial left\nventricular hypertrophy if rhythm control is preferred over\nrate control",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 42,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Amitriptyline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 43,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Amoxapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 44,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Clomipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 45,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Desipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 46,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Doxepin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : ">6 mg\/day",
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 47,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Imipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 48,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Nortriptyline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 49,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Paroxetine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 50,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Protriptyline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 51,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Trimipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Highly anticholinergic, sedating, and cause orthostatic hypotension; safety profile of low-dose doxepin (â‰¤6 mg\/day) comparable to that of placebo",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 53,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Amobarbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 54,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Butabarbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 55,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Butalbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 56,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Mephobarbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 57,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Pentobarbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 58,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Phenobarbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 59,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Secobarbital",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence, tolerance to sleep benefits, greater risk of overdose at low dosages",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 60,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Alprazolam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 61,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Estazolam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 62,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Lorazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 63,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Oxazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 64,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Temazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 65,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Triazolam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 66,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Chlordiazepoxide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Alone or in combination with amitriptyline or clidinium",
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 67,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Clonazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 68,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Clorazepate",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 69,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Diazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 70,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Flurazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 71,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Quazepam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of longacting agents; in general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 72,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Meprobamate",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "High rate of physical dependence; sedating",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 73,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Eszopiclone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (ie, Z drugs) have adverse events similar to those of benzodiazepines in older adults (eg, delirium, falls, fractures); increased emergency room visits\/ hospitalizations; motor vehicle crashes; minimal improvement in sleep latency and duration",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 74,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Zaleplon",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (ie, Z drugs) have adverse events similar to those of benzodiazepines in older adults (eg, delirium, falls, fractures); increased emergency room visits\/ hospitalizations; motor vehicle crashes; minimal improvement in sleep latency and duration",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 75,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Zolpidem",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (ie, Z drugs) have adverse events similar to those of benzodiazepines in older adults (eg, delirium, falls, fractures); increased emergency room visits\/ hospitalizations; motor vehicle crashes; minimal improvement in sleep latency and duration",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 76,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Ergoloid mesylates",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Lack of efficacy",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 77,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Isoxsuprine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Lack of efficacy",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 78,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Methyltestosterone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "indication for confirmed hypogonadism with clinical symptoms",
		"Rationale" : "Potential for cardiac problems; contraindicated in men with prostate cancer",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 79,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Testosterone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "indication for confirmed hypogonadism with clinical symptoms",
		"Rationale" : "Potential for cardiac problems; contraindicated in men with prostate cancer",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 80,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Desiccated thyroid",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Concerns about cardiac effects; safer alternatives\navailable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 81,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Estrogens",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "With or without progrestins. Systemic estrogen (eg, oral and topical patch) Vaginal cream or vaginal tablets: acceptable to use low-dose intravaginal estrogen for management of dyspareunia, recurrent lower urinary tract infections, and other vaginal symptoms",
		"Exclusion" : null,
		"Rationale" : "Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (dosages of estradiol <25 Î¼g twice weekly) with their healthcare provider",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 82,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Growth hormone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "In all cases EXCEPT for patients rigorously diagnosed by evidence-based criteria with growth hormone deficiency due to an established etiology",
		"Exclusion" : null,
		"Rationale" : "Impact on body composition is small and associated with edema, arthralgia, carpal tunnel syndrome, gynecomastia, impaired fasting glucose",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 83,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Insulin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "sliding scale (insulin regimens containing only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin)",
		"Exclusion" : null,
		"Rationale" : "Higher risk of hypoglycemia without improvement in\nhyperglycemia management regardless of care setting.\nAvoid insulin regimens that include only short- or rapidacting insulin dosed according to current blood glucose\nlevels without concurrent use of basal or long-acting\ninsulin. This recommendation does not apply to regimens\nthat contain basal insulin or long-acting insulin.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 84,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Megestrol",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Minimal effect on weight; increases risk of thrombotic events and possibly death in older adults",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 85,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Chlorpropamide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Chlorpropamide: prolonged half-life in older adults; can cause prolonged hypoglycemia; causes SIADH ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 86,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Glimepiride",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Glimepiride and glyburide: higher risk of severe prolonged hypoglycemia in older adults",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 87,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Glyburide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Glimepiride and glyburide: higher risk of severe prolonged hypoglycemia in older adults",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 88,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Metoclopramide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "gastroparesis with duration of use not to exceed 12 weeks except in rare cases",
		"Rationale" : "Can cause extrapyramidal effects, including tardive\ndyskinesia; risk may be greater in frail older adults and\nwith prolonged exposure",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 89,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Mineral Oil",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Oral",
		"Exclusion" : null,
		"Rationale" : "Potential for aspiration and adverse effects; safer alternatives available",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 91,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Meperidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Oral analgesic not effective in dosages commonly used; may have higher risk of neurotoxicity, including delirium, than other opioids; safer alternatives available",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 92,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Aspirin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : ">325 mg. Oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : "<325 mg",
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 93,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Diclofenac",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 94,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Diflunisal",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 95,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Etodolac",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 96,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Fenoprofen",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 97,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Ibuprofen",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 98,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Ketoprofen",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 99,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Meclofenamate",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 100,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Mefenamic acid",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 101,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Meloxicam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 102,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Nabumetone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 103,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Naproxen",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 104,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Oxaprozin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 105,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Piroxicam",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 106,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Sulindac",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 107,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Tolmetin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral, chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding or peptic ulcer disease in high-risk groups, including those >75 years or taking oral or parenteral corticosteroids, anticoagulants, or antiplatelet agents; use of proton-pump inhibitor or misoprostol reduces but does not eliminate risk. Upper gastrointestinal ulcers, gross bleeding, or perforation caused by Non-steroidal Anti-inflammatory Drugs occur in ~1% of patients treated for 3-6 months and in ~2%-4% of patients treated for 1 year; these trends continue with longer duration of use. Also can increase blood pressure and induce kidney injury. Risks are dose related.",
		"Recommendation" : "Avoid ",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 108,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Indomethacin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol)",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding\/peptic ulcer disease and acute kidney injury in older adults Indomethacin is more likely than other Non-steroidal Anti-inflammatory Drugs to have adverse CNS effects. Of all the Non-steroidal Anti-inflammatory Drugs, indomethacin has the most adverse effects",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 109,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Ketorolac",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Chronic use, unless other alternatives are not effective and patient can take gastroprotective agent (proton-pump inhibitor or misoprostol). Includes parenteral",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding\/peptic ulcer disease and acute kidney injury in older adults Indomethacin is more likely than other Non-steroidal Anti-inflammatory Drugs to have adverse CNS effects. Of all the Non-steroidal Anti-inflammatory Drugs, indomethacin has the most adverse effects",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 110,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Carisoprodol",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 111,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Chlorzoxazone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 112,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Cyclobenzaprine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 113,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Metaxalone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 114,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Methocarbamol",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 115,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Orphenadrine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Most muscle relaxants poorly tolerated by older adults because some have anticholinergic adverse effects, sedation, increased risk of fractures; effectiveness at dosages tolerated by older adults questionable",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 116,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Desmopressin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Nocturia or nocturnal polyuria",
		"Exclusion" : null,
		"Rationale" : "High risk of hyponatremia; safer alternative treatments",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 117,
		"DiseaseState" : "Asymptomatic Heart Failure, Symptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Cilostazol",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 305,
		"DiseaseState" : "Heart Failure with Reduced Ejection Fraction (HFrEF)",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Verapamil",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Reduced Ejection Fraction",
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 306,
		"DiseaseState" : "Heart Failure with Reduced Ejection Fraction (HFrEF)",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Diltiazem",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Reduced Ejection Fraction",
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 121,
		"DiseaseState" : "Symptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Thiazolidinediones",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 122,
		"DiseaseState" : "Symptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Dronedarone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 126,
		"DiseaseState" : "Asymptomatic Heart Failure",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Dronedarone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Potential to promote fluid retention and\/or exacerbate heart failure (Non-steroidal Anti-inflammatory Drugs and COX-2 inhibitors, nondihydropyridine CCBs, thiazolidinediones); potential to increase mortality in older adults with heart failure (cilostazol and dronedarone)",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 129,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Terazosin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 130,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Prazosin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 131,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Doxazosin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 133,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Chlorpromazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 134,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Thioridazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 135,
		"DiseaseState" : "Syncope",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Olanzapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "AChEIs cause bradycardia and should be avoided in older adults whose syncope may be due to bradycardia. Nonselective peripheral alpha-1 blockers cause orthostatic blood pressure changes and should be avoided in older adults whose syncope may be due to orthostatic hypotension. Tertiary Tricyclic Antidepressants and the antipsychotics listed increase the risk of orthostatic hypotension or bradycardia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 140,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Cimetidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 141,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Famotidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 142,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Nizatidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 143,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Ranitidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 144,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Meperidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 147,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "eszopiclone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 148,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "zaleplon",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 149,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "zolpidem",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 150,
		"DiseaseState" : "Dementia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "eszopiclone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 151,
		"DiseaseState" : "Dementia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "zaleplon",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 152,
		"DiseaseState" : "Dementia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "zolpidem",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 159,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Eszopiclone",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 160,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Zaleplon",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 161,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Zolpidem",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 165,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Analgesics",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Severe acute pain (recent fractures or joint replacement",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 166,
		"DiseaseState" : "Parkinson disease",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Metoclopramide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 167,
		"DiseaseState" : "Parkinson disease",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Prochlorperazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 168,
		"DiseaseState" : "Parkinson disease",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Promethazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 170,
		"DiseaseState" : "History of gastric or\r\nduodenal ulcers",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Aspirin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Other alternatives not effective and patient can take gastroprotective agent (proton pump inhibitor or misoprostol)",
		"Rationale" : "May exacerbate existing ulcers or cause new\/additional ulcers",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 172,
		"DiseaseState" : "Urinary incontinence (all types) in women",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Estrogen",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Oral and transdermal",
		"Exclusion" : "intravaginal estrogen",
		"Rationale" : "Lack of efficacy (oral estrogen) and\naggravation of incontinence (alpha-1\nblockers)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 174,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Aspirin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Primary prevention of cardiovascular disease and colorectal cancer AND >70 years old",
		"Exclusion" : null,
		"Rationale" : "Risk of major bleeding from aspirin increases markedly in older age. Several studies suggest lack of net benefit when used for primary prevention in older adult with cardiovascular risk factors, but evidence is not conclusive. Aspirin is generally indicated for secondary prevention in older adults with established cardiovascular disease.",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 176,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Dabigatran",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "treatment of VTE or atrial fibrillation in adults â‰¥75 years",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding compared with warfarin and reported rates with other direct oral anticoagulants when used for long-term treatment of VTE or atrial fibrillation in adults â‰¥75 years.",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 177,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Rivaroxaban",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "treatment of VTE or atrial fibrillation in adults â‰¥75 years",
		"Exclusion" : null,
		"Rationale" : "Increased risk of gastrointestinal bleeding compared with warfarin and reported rates with other direct oral anticoagulants when used for long-term treatment of VTE or atrial fibrillation in adults â‰¥75 years.",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 178,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Prasugrel",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : ">=75 years",
		"Exclusion" : "adults with prior risk of myocardial infarction or diabetes mellitus",
		"Rationale" : "may offset risk when used for its approved indication of acute coronary syndrome to be managed with percutaneous coronary intervention.",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 180,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Carbamazepine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 182,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Mirtazapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 183,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Oxcarbazepine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 187,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Tramadol",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 188,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Dextromethorphan\/quinidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "treatment of pseudobular affect",
		"Rationale" : "Limited efficacy in patients with behavioral symptoms of dementia. May increase risk of falls and concerns with clinically significant drug interactions. ",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 189,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Trimethoprim-sulfamethoxazole",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and decreased  creatinine clearance",
		"Exclusion" : null,
		"Rationale" : "Increased risk of hyperkalemia when used concurrently with an ACEI or ARB in presence of decreased creatinine clearance",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 193,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "amiloride",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "another RAS inhibitor",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of hyperkalemia ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 194,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "triamterene",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "another RAS inhibitor",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of hyperkalemia ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 207,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Lithium",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "angiotensin-converting enzyme inhibitors",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of lithium toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor lithium concentrations",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 208,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Lithium",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Loop diuretics",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of lithium toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor lithium concentrations",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 210,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Phenytoin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Trimethoprim-sulfamethoxazole",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of phenytoin toxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 211,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Theophylline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Cimetidine",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of theophylline\ntoxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 212,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Theophylline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Ciprofloxacin",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of theophylline\ntoxicity",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 213,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Warfarin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Amiodarone",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor INR closely if not possible to avoid",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 214,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Warfarin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Ciprofloxacin",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor INR closely if not possible to avoid",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 215,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Warfarin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Macrolides",
		"Inclusion" : null,
		"Exclusion" : "Azithromycin",
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor INR closely if not possible to avoid",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 216,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Warfarin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Trimethoprim-sulfamethoxazole",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor INR closely if not possible to avoid",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 217,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Warfarin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Non-steroidal Anti-inflammatory Drugs",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Monitor INR closely if not possible to avoid",
		"ItemType" : "drug",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 218,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Ciprofloxacin",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of CNS effects\n(eg, seizures, confusion) and\ntendon rupture",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 219,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "trimethoprim-sulfamethoxazole",
		"LowerLimit" : 15,
		"UpperLimit" : 29,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of worsening of\nrenal function and hyperkalemia",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 220,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "trimethoprim-sulfamethoxazole",
		"LowerLimit" : null,
		"UpperLimit" : 15,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of worsening of\nrenal function and hyperkalemia",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 221,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "amiloride",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased potassium and\ndecreased sodium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 222,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "apixaban",
		"LowerLimit" : null,
		"UpperLimit" : 25,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Lack of evidence for efficacy\nand safety in patients with a\nCrCl <25 mL\/min",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 223,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "dabigatran",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Lack of evidence for efficacy\nand safety in individuals with a\nCrCl <30 mL\/min. Label dose\nfor patients with a CrCl\n15-30 mL\/min based on\npharmacokinetic data.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : "Dose adjust when CrCl > 30 mL\/min w\/ drug-drug interactions",
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 224,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "dofetilide",
		"LowerLimit" : 20,
		"UpperLimit" : 60,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "QTc prolongation and torsade\nde pointes",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 225,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "edoxaban",
		"LowerLimit" : 15,
		"UpperLimit" : 50,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Lack of evidence of efficacy or\nsafety in patients with a CrCl\n<30 mL\/min",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 226,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "edoxaban",
		"LowerLimit" : 95,
		"UpperLimit" : 15,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Lack of evidence of efficacy or\nsafety in patients with a CrCl\n<30 mL\/min",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 227,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "enoxaparin",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 228,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "fondaparinux",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of bleeding",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 229,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "rivaroxaban",
		"LowerLimit" : null,
		"UpperLimit" : 50,
		"DrugInteraction" : null,
		"Inclusion" : "Nonvalvular Atrial fibrillation",
		"Exclusion" : null,
		"Rationale" : "Lack of efficacy or safety\nevidence in patients with a CrCl\n<30 mL\/min",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 230,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "rivaroxaban",
		"LowerLimit" : null,
		"UpperLimit" : 15,
		"DrugInteraction" : null,
		"Inclusion" : "Nonvalvular Atrial fibrillation",
		"Exclusion" : null,
		"Rationale" : "Lack of efficacy or safety\nevidence in patients with a CrCl\n<30 mL\/min",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 231,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "rivaroxaban",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : "Venous thromboembolism treatment OR VTE prophylaxis with hip or knee replacement",
		"Exclusion" : null,
		"Rationale" : "Lack of efficacy or safety\nevidence in patients with a CrCl\n<30 mL\/min",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 232,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Spironolactone",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased potassium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 233,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Triamterene",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased potassium and\ndecreased sodium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 234,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Duloxetine",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased gastrointestinal\nadverse effects (nausea,\ndiarrhea)",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 235,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Gabapentin",
		"LowerLimit" : null,
		"UpperLimit" : 60,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "CNS adverse effects",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 236,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Levetiracetam",
		"LowerLimit" : null,
		"UpperLimit" : 81,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "CNS adverse effects",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 237,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Pregabalin",
		"LowerLimit" : null,
		"UpperLimit" : 60,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "CNS adverse effects",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 238,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Tramadol",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : "Immediate release",
		"Exclusion" : null,
		"Rationale" : "CNS adverse effects",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 239,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Tramadol",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : "Extended release",
		"Exclusion" : null,
		"Rationale" : "CNS adverse effects",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 240,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Cimetidine",
		"LowerLimit" : null,
		"UpperLimit" : 50,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Mental status changes",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 241,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Famotidine",
		"LowerLimit" : null,
		"UpperLimit" : 50,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Mental status changes",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 242,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Nizatidine",
		"LowerLimit" : null,
		"UpperLimit" : 50,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Mental status changes",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 243,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Ranitidine",
		"LowerLimit" : null,
		"UpperLimit" : 50,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Mental status changes",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 244,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Colchicine",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Gastrointestinal,\nneuromuscular, bone marrow\ntoxicity",
		"Recommendation" : "Reduce dose",
		"RecommendationLineTwo" : "Monitor for adverse effects",
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 245,
		"DiseaseState" : null,
		"Category" : 6,
		"TableDefinition" : "Medications That Should Be Avoided or Have Their Dosage Reduced With Varying Levels of Kidney Function in Older Adults",
		"Item" : "Probenecid",
		"LowerLimit" : null,
		"UpperLimit" : 30,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Loss of effectiveness",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Renally Affected Drugs"
	},
	{
		"EntryID" : 246,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Promethazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 247,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Disopyramide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 248,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Triprolidine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 249,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Pyrilamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 250,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Amitriptyline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 251,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Amoxapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 252,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Clomipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 253,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Desipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 254,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Doxepin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : ">6 mg",
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 255,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Imipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 256,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Nortriptyline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 257,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Paroxetine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 258,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Protriptyline",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 259,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Trimipramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 260,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Trospium",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 261,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Fesoterodine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 262,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Flavoxate",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 263,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Oxybutynin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 264,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Solifenacin",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 265,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Tolterodine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 266,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Prochlorperazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 267,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Promethazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 268,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Trihexyphenidyl",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 269,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Benztropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 270,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Brompheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 271,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Carbinoxamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 272,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Chlorpheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 273,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Clemastine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 274,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Cyproheptadine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 275,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Dexbrompheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 276,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Dexchlorpheniramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 277,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Dimenhydrinate",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 278,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Diphenhydramine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : "oral",
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 279,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Doxylamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 280,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Hydroxyzine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 282,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Meclizine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 283,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Clidinium-chlordiazepoxide",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 285,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Dicyclomine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 286,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Homatropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : "opthalmic",
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 288,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Scopolamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : "opthalmic",
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 289,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Hyoscyamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 290,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Methscopolamine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 291,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Belladonna alkaloids",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 292,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Cyclobenzaprine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 293,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Orphenadrine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 294,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Chlorpromazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 295,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Clozapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 296,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Loxapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 297,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Olanzapine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 298,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Perphenazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 299,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Thioridazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 300,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Trifluoperazine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 302,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Antispasmodics",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 303,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Atropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : "opthalmic",
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 304,
		"DiseaseState" : null,
		"Category" : 7,
		"TableDefinition" : "Drugs With Strong Anticholinergic Properties",
		"Item" : "Benztropine",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Strong anticholinergic properties",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : null,
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Anticholinergics"
	},
	{
		"EntryID" : 26,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Dipyridamole",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "oral short acting",
		"Exclusion" : null,
		"Rationale" : "May cause orthostatic hypotension; more effective\nalternatives available; IV form acceptable for use in\ncardiac stress testing",
		"Recommendation" : null,
		"RecommendationLineTwo" : null,
		"ItemType" : "drug",
		"ShortTableName" : "Potentially Innappropriate"
	},
	{
		"EntryID" : 136,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Anticholinergic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 137,
		"DiseaseState" : "Delirium",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Avoid antipsychotics for behavioral\nproblems of dementia and\/or delirium\nunless nonpharmacological options (eg,\nbehavioral interventions) have failed or\nare not possible and the older adult is\nthreatening substantial harm to self or\nothers. Antipsychotics are associated\nwith greater risk of cerebrovascular\naccident (stroke) and mortality in\npersons with dementia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 153,
		"DiseaseState" : "Dementia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Anticholinergic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Older adults with or at risk of delirium ",
		"Exclusion" : null,
		"Rationale" : "Can induce or worsen delirium",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 155,
		"DiseaseState" : "Dementia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Avoid antipsychotics for behavioral\nproblems of dementia and\/or delirium\nunless nonpharmacological options (eg,\nbehavioral interventions) have failed or\nare not possible and the older adult is\nthreatening substantial harm to self or others. Antipsychotics are associated\nwith greater risk of cerebrovascular\naccident (stroke) and mortality in persons\nwith dementia",
		"Exclusion" : null,
		"Rationale" : "Avoid antipsychotics for behavioral\nproblems of dementia and\/or delirium\nunless nonpharmacological options (eg,\nbehavioral interventions) have failed or\nare not possible and the older adult is\nthreatening substantial harm to self or\nothers. Antipsychotics are associated\nwith greater risk of cerebrovascular\naccident (stroke) and mortality in\npersons with dementia.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 156,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Antiepileptic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 157,
		"DiseaseState" : "History of falls or\r\nfractures",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Safer alternatives are not available. Avoid epileptics except for seizure and mood disorders",
		"Rationale" : "May cause ataxia, impaired psychomotor function, syncope, additional falls; shorteracting benzodiazepines are not safer than long-acting ones. If one of the drugs must be used, consider reducing use of other CNS-active medications that increase risk of falls and fractures (ie, antiepileptics, opioid-receptor agonists, antipsychotics, antidepressants, nonbenzodiazepine and benzodiazepine receptor agonist hypnotics, other sedatives\/hypnotics) and implement other strategies to reduce fall risk. Data for antidepressants are mixed but no compelling evidence that certain antidepressants confer less fall risk than others.",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 169,
		"DiseaseState" : "Parkinson disease",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : "Quetiapine, clozapine, pimavanserin: Pimavanserin and clozapine appear to be less likely to precipitate worsening of Parkinson disease. Quetiapine has only been studied in low-quality clinical trials with efficacy comparable to thatof placebo in five trials and to that of clozapine in two others.",
		"Rationale" : "Dopamine-receptor antagonists with potential to worsen parkinsonian symptoms",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 173,
		"DiseaseState" : "Lower urinary tract\r\nsymptoms, benign\r\nprostatic hyperplasia",
		"Category" : 3,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults Due to Drug-Disease or Drug-Syndrome Interactions That May Exacerbate the Disease or Syndrome",
		"Item" : "Anticholinergics",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "Men",
		"Exclusion" : "Weak or antimuscarinics used for urinary incontinence",
		"Rationale" : "May decrease urinary flow and cause\nurinary retention",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Disease-Specific Guidance"
	},
	{
		"EntryID" : 179,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 181,
		"DiseaseState" : null,
		"Category" : 4,
		"TableDefinition" : "Drugs To Be Used With Caution in Older Adults",
		"Item" : "Diuretic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults",
		"Recommendation" : "Caution",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Use with Caution"
	},
	{
		"EntryID" : 199,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Antidepressant",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 200,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 201,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Antiepileptic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Antidepressants (Tricyclic Antidepressants, Selective Serotonin Receptor Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors)\nAntipsychotics\nAntiepileptics\nBenzodiazepines and\nnonbenzodiazepine, benzodiazepine\nreceptor agonist hypnotics\n(ie, â€œZ-drugsâ€)\nOpioids",
		"Inclusion" : "total of three or more\nCNS-active drugs",
		"Exclusion" : null,
		"Rationale" : "Increased risk of falls ",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 198,
		"DiseaseState" : null,
		"Category" : 5,
		"TableDefinition" : "Potentially Inappropriate Medications: Drugs To Be Used With Caution in Older Adults",
		"Item" : "Anticholinergic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : "Anticholinergic",
		"Inclusion" : null,
		"Exclusion" : null,
		"Rationale" : "Increased risk of cognitive\ndecline",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Drug-Drug Interactions"
	},
	{
		"EntryID" : 52,
		"DiseaseState" : null,
		"Category" : 2,
		"TableDefinition" : "Potentially Inappropriate Medication Use in Older Adults ",
		"Item" : "Antipsychotic",
		"LowerLimit" : null,
		"UpperLimit" : null,
		"DrugInteraction" : null,
		"Inclusion" : "first and second generation",
		"Exclusion" : "schizophrenia or\nbipolar disorder, or for short-term use\nas antiemetic during chemotherapy",
		"Rationale" : "Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia Avoid antipsychotics for behavioral problems of dementia or delirium unless nonpharmacological options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others",
		"Recommendation" : "Avoid",
		"RecommendationLineTwo" : null,
		"ItemType" : "therapeutic category",
		"ShortTableName" : "Potentially Innappropriate"
	}
]}
